| abstract |
Provided are a quinoline or quinazoline derivative having a structure of formula (I), a pharmaceutical composition comprising the compound of formula (I), and use of the compound in the preparation of a medicament for preventing or treating diseases associated with the human epidermal growth factor receptor Her/erbB family, in particular for preventing or treating tumors associated with protein tyrosine kinases. Each substituent in formula (I) has the same definition as that in the description. |